Literature DB >> 2005474

Assessing HIV infection in primary care practice.

H J Makadon1.   

Abstract

In routine office practice, primary care physicians see both individuals at risk for HIV infection and those who are already infected. They must be prepared to assess risks of HIV infection in all patients, counsel patients with histories of high-risk behavior about the reasons to be tested for infection, and explain the meanings of both positive and negative test results. The initial medical evaluation of an infected individual should include a history and physical examination to detect early manifestations of HIV infection, basic diagnostic tests, including CD4 counts and a purified protein derivative test, and immunization against potentially preventable infections.

Entities:  

Mesh:

Year:  1991        PMID: 2005474     DOI: 10.1007/bf02599250

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  10 in total

1.  Reducing HIV transmission in intravenous-drug users not in drug treatment--United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1990-08-10       Impact factor: 17.586

Review 2.  Natural history of HIV infection.

Authors:  A R Moss; P Bacchetti
Journal:  AIDS       Date:  1989-02       Impact factor: 4.177

3.  Screening for tuberculosis and tuberculous infection in high-risk populations. Recommendations of the Advisory Committee for Elimination of Tuberculosis.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1990-05-18

Review 4.  Pneumocystis carinii pneumonia: therapy and prophylaxis.

Authors:  J A Kovacs; H Masur
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226

Review 5.  Routine immunization of the HIV-positive asymptomatic patient.

Authors:  G A Poland; K R Love; C E Hughes
Journal:  J Gen Intern Med       Date:  1990 Mar-Apr       Impact factor: 5.128

6.  General recommendations on immunization. Guidelines from the Immunization Practices Advisory Committee. Centers for Disease Control.

Authors: 
Journal:  Ann Intern Med       Date:  1989-07-15       Impact factor: 25.391

7.  AIDS-related competence of California's primary care physicians.

Authors:  C E Lewis; H E Freeman; C R Corey
Journal:  Am J Public Health       Date:  1987-07       Impact factor: 9.308

8.  Clinical, immunologic, and serologic findings in men at risk for acquired immunodeficiency syndrome. The San Francisco Men's Health Study.

Authors:  W Lang; R E Anderson; H Perkins; R M Grant; D Lyman; W Winkelstein; R Royce; J A Levy
Journal:  JAMA       Date:  1987-01-16       Impact factor: 56.272

Review 9.  Voluntary screening for human immunodeficiency virus (HIV) infection. Weighing the benefits and harms.

Authors:  B Lo; R L Steinbrook; M Cooke; T J Coates; E J Walters; S B Hulley
Journal:  Ann Intern Med       Date:  1989-05-01       Impact factor: 25.391

10.  Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.

Authors:  P A Volberding; S W Lagakos; M A Koch; C Pettinelli; M W Myers; D K Booth; H H Balfour; R C Reichman; J A Bartlett; M S Hirsch
Journal:  N Engl J Med       Date:  1990-04-05       Impact factor: 91.245

  10 in total
  3 in total

1.  Clinicians, educators, and investigators in general internal medicine: bridging the gaps.

Authors:  Kenneth J Mukamal; Gerald W Smetana; Tom Delbanco
Journal:  J Gen Intern Med       Date:  2002-07       Impact factor: 5.128

Review 2.  Physicians and AIDS: sexual risk assessment of patients and willingness to treat HIV-infected patients.

Authors:  B Gerbert; T Bleecker; B T Maguire; N Caspers
Journal:  J Gen Intern Med       Date:  1992 Nov-Dec       Impact factor: 5.128

3.  The ambulatory care of HIV-infected persons: a survey of physician practice patterns.

Authors:  M D Stein; P O'Sullivan; L Rubenstein; P Weller; T Wachtel
Journal:  J Gen Intern Med       Date:  1992 Mar-Apr       Impact factor: 5.128

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.